Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CAH NYSE:COR NYSE:ELV NYSE:MCK On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCAHCardinal Health$200.42-0.1%$205.21$137.75▼$233.60$47.00B0.532.57 million shs1.54 million shsCORCencora$275.01+3.6%$305.70$244.82▼$377.54$53.49B0.642.30 million shs2.14 million shsELVElevance Health$394.41+1.2%$333.81$273.71▼$408.00$85.71B0.661.72 million shs1.09 million shsMCKMcKesson$765.30-0.2%$838.23$637.00▼$999.00$92.09B0.351.27 million shs2.32 million shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for June 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCAHCardinal Health0.00%+2.73%-2.19%-10.61%+30.76%CORCencora0.00%+7.02%-11.66%-23.76%-5.64%ELVElevance Health0.00%+0.43%+13.94%+15.00%-1.42%MCKMcKesson0.00%+0.72%-8.45%-19.22%+6.59%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCAHCardinal Health$200.42-0.1%$205.21$137.75▼$233.60$47.00B0.532.57 million shs1.54 million shsCORCencora$275.01+3.6%$305.70$244.82▼$377.54$53.49B0.642.30 million shs2.14 million shsELVElevance Health$394.41+1.2%$333.81$273.71▼$408.00$85.71B0.661.72 million shs1.09 million shsMCKMcKesson$765.30-0.2%$838.23$637.00▼$999.00$92.09B0.351.27 million shs2.32 million shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for June 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCAHCardinal Health0.00%+2.73%-2.19%-10.61%+30.76%CORCencora0.00%+7.02%-11.66%-23.76%-5.64%ELVElevance Health0.00%+0.43%+13.94%+15.00%-1.42%MCKMcKesson0.00%+0.72%-8.45%-19.22%+6.59%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCAHCardinal Health 2.94Moderate Buy$241.8020.65% UpsideCORCencora 2.80Moderate Buy$380.2538.27% UpsideELVElevance Health 2.61Moderate Buy$399.321.24% UpsideMCKMcKesson 2.82Moderate Buy$968.8726.60% UpsideCurrent Analyst Ratings BreakdownLatest COR, ELV, MCK, and CAH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/22/2026CORCencora Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy (B) ➝ Buy (B-)5/22/2026ELVElevance Health UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$400.00 ➝ $460.005/20/2026ELVElevance Health MizuhoSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$385.00 ➝ $435.005/20/2026ELVElevance Health Deutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Buy$363.00 ➝ $498.005/19/2026CAHCardinal Health Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy (B+) ➝ Buy (B)5/19/2026ELVElevance Health EvercoreSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold5/18/2026ELVElevance Health Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold (C-) ➝ Hold (C)5/18/2026MCKMcKesson Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy (B+) ➝ Buy (B)5/14/2026MCKMcKesson CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$975.00 ➝ $945.005/12/2026MCKMcKesson Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetEqual Weight$925.00 ➝ $812.005/11/2026CORCencora Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOverweight$429.00 ➝ $331.00(Data available from 5/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCAHCardinal Health$222.58B0.21$11.65 per share17.20($11.41) per share-17.56CORCencora$321.33B0.17$21.62 per share12.72$18.43 per share14.92ELVElevance Health$199.13B0.43$37.56 per share10.50$202.81 per share1.94MCKMcKesson$403.43B0.23$45.53 per share16.81($14.78) per share-51.78Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCAHCardinal Health$1.56B$6.5430.6416.791.190.62%-92.61%4.46%8/11/2026 (Estimated)CORCencora$1.55B$13.0421.0913.971.270.78%135.20%4.20%8/5/2026 (Estimated)ELVElevance Health$5.66B$23.5116.7813.522.232.62%15.58%5.57%7/16/2026 (Estimated)MCKMcKesson$4.76B$38.4719.8915.321.141.18%-345.35%5.85%8/5/2026 (Estimated)Latest COR, ELV, MCK, and CAH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2026Q4 2026MCKMcKesson$11.56$11.69+$0.13$13.71$101.35 billion$96.30 billion5/6/2026Q2 2026CORCencora$4.82$4.75-$0.07$8.40$81.09 billion$78.36 billion4/30/2026Q3 2026CAHCardinal Health$2.79$3.17+$0.38$1.69$62.10 billion$60.94 billion4/22/2026Q1 2026ELVElevance Health$10.74$12.58+$1.84$8.00$48.21 billion$49.49 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCAHCardinal Health$2.041.02%+1.02%31.19%29 YearsCORCencora$2.400.87%+5.79%18.40%15 YearsELVElevance Health$6.881.74%+12.47%29.26%14 YearsMCKMcKesson$3.280.43%+13.68%8.53%17 YearsLatest COR, ELV, MCK, and CAH DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/5/2026CAHCardinal Healthquarterly$0.51581.05%7/1/20267/1/20267/15/20264/21/2026MCKMcKessonquarterly$0.820.4%6/1/20266/1/20267/1/20264/21/2026ELVElevance Healthquarterly$1.722.11%6/10/20266/10/20266/25/20265/5/2026CORCencoraquarterly$0.600.93%5/15/20265/15/20266/1/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCAHCardinal HealthN/A0.910.48CORCencora3.400.950.59ELVElevance Health0.701.481.48MCKMcKessonN/A0.850.49Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCAHCardinal Health87.17%CORCencora97.52%ELVElevance Health89.24%MCKMcKesson85.07%Insider OwnershipCompanyInsider OwnershipCAHCardinal Health0.12%CORCencora0.38%ELVElevance Health0.34%MCKMcKesson0.08%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCAHCardinal Health57,700234.21 million233.93 millionOptionableCORCencora51,000194.56 million193.82 millionOptionableELVElevance Health97,100217.16 million216.42 millionOptionableMCKMcKesson43,000120.20 million120.11 millionOptionableCOR, ELV, MCK, and CAH HeadlinesRecent News About These CompaniesGlobal Retirement Partners LLC Grows Stock Position in McKesson Corporation $MCKMay 23 at 5:40 AM | marketbeat.comCumberland Partners Ltd Sells 2,415 Shares of McKesson Corporation $MCKMay 23 at 4:25 AM | marketbeat.comHere's Why You Should Retain McKesson Stock in Your Portfolio for NowMay 22 at 6:04 PM | finance.yahoo.comA Look Back at Healthcare Providers & Services Stocks’ Q1 Earnings: McKesson (NYSE:MCK) Vs The Rest Of The PackMay 22 at 6:04 PM | finance.yahoo.comHere's Why You Should Retain McKesson Stock in Your Portfolio for NowMay 22 at 1:21 PM | zacks.comTBRG Posts Q1 Earnings: How to Play the Stock Amid Pending Sell-off?May 22 at 1:03 PM | finance.yahoo.comAre Wall Street Analysts Predicting McKesson Stock Will Climb or Sink?May 22 at 9:51 AM | barchart.comA look back at healthcare providers & services stocks’ Q1 earnings: McKesson (NYSE:MCK) vs the rest of the packMay 21 at 9:51 AM | msn.comOntada Integrates Florida Cancer Specialists & Research Institute Data to Enrich Its Data EcosystemMay 21 at 9:51 AM | finance.yahoo.comRathbones Group PLC Has $33.78 Million Position in McKesson Corporation $MCKMay 21 at 6:17 AM | marketbeat.comPNC Financial Services Group Inc. Has $200.49 Million Holdings in McKesson Corporation $MCKMay 21 at 5:33 AM | marketbeat.com1 of Wall Street’s Favorite Stock with Impressive Fundamentals and 2 We AvoidMay 20, 2026 | finance.yahoo.comWhat Makes McKesson Corporation (MCK) an Attractive Bet?May 20, 2026 | insidermonkey.comWhat Makes McKesson Corporation (MCK) an Attractive Bet?May 20, 2026 | finance.yahoo.comBanque Cantonale Vaudoise Grows Holdings in McKesson Corporation $MCKMay 20, 2026 | marketbeat.comMcKesson Corp. stock outperforms competitors despite losses on the dayMay 19, 2026 | marketwatch.comMcKesson Corporation $MCK Stock Holdings Lowered by Tredje AP fondenMay 19, 2026 | marketbeat.comResona Asset Management Co. Ltd. Sells 3,239 Shares of McKesson Corporation $MCKMay 19, 2026 | marketbeat.comNorthwestern Mutual Wealth Management Co. Grows Stock Position in McKesson Corporation $MCKMay 19, 2026 | marketbeat.comHandelsbanken Fonder AB Purchases 38,439 Shares of McKesson Corporation $MCKMay 19, 2026 | marketbeat.comMcKesson Corporation (MCK) Highlights Resilience as Its Core Drug Distribution Network Stands the Test of TimeMay 18, 2026 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesApple Talks Just Changed Everything for IntelBy Sam Quirke | May 6, 2026Before the Moon Base Gets Built, These 4 Companies WinBy Thomas Hughes | May 11, 2026Roblox Stock Slides to New Low as Safety Changes Weigh on OutlookBy Jennifer Ryan Woods | May 3, 2026Beyond NVIDIA: Picks-and-Shovels AI Plays with Strong MomentumBy Chris Markoch | May 10, 2026The Crude Reality: Pullback Creates High-Conviction Opportunity in ChevronBy Jeffrey Neal Johnson | April 29, 2026COR, ELV, MCK, and CAH Company DescriptionsCardinal Health NYSE:CAH$200.42 -0.20 (-0.10%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$200.29 -0.13 (-0.06%) As of 05/22/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.Cencora NYSE:COR$275.01 +9.57 (+3.60%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$275.25 +0.24 (+0.09%) As of 05/22/2026 07:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.Elevance Health NYSE:ELV$394.41 +4.59 (+1.18%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$394.60 +0.19 (+0.05%) As of 05/22/2026 05:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.McKesson NYSE:MCK$765.30 -1.20 (-0.16%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$766.28 +0.97 (+0.13%) As of 05/22/2026 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/18 - 05/22 Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus? Workday Validates AI Flywheel: Stock Price Recovery Begins SpaceX IPO: Opportunity? Or the Ultimate Hype Trade? Overextended, e.l.f. Beauty Is Primed to Rebound in Back Half Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook NVIDIA Price Pullback? Don’t Count on It, Business Is Accelerating Palantir and Dell Build an AI OS for the Paranoid Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
